---
title: Psychedelics and their effects on the brain
videoId: fpwDi8f6TLQ
---

From: [[⁨cleoabram⁩]] <br/> 

## What Are Psychedelics?

Psychedelics encompass a large category of drugs, including substances commonly known as ecstasy, acid, molly, and magic mushrooms <a class="yt-timestamp" data-t="00:02:27">[00:02:27]</a>. Some historical street names include "Angels in the Sky," "El Gata Diablo," "Electric Kool-Aid," "Mother of God," and "White Lightning" <a class="yt-timestamp" data-t="00:02:40">[00:02:40]</a>.

The term "psychedelic" is derived from Greek words that loosely translate to "mind manifesting" <a class="yt-timestamp" data-t="00:03:11">[00:03:11]</a>. These drugs are known for their profound ability to change one's perception of the world and self <a class="yt-timestamp" data-t="00:03:31">[00:03:31]</a>. When people take them, they often report seeing vivid colors or moving shapes, and experiencing or grappling with intense emotions <a class="yt-timestamp" data-t="00:03:15">[00:03:15]</a>.

### How They Work

"Classic psychedelics" primarily act on the same serotonin receptor in the brain, known as the 2A receptor <a class="yt-timestamp" data-t="00:02:57">[00:02:57]</a>. While MDMA and Ketamine are generally classified under the umbrella of psychedelics, they operate somewhat differently in the brain <a class="yt-timestamp" data-t="00:03:03">[00:03:03]</a>.

Researchers now believe these drugs alter the conversations between individual brain cells <a class="yt-timestamp" data-t="00:08:43">[00:08:43]</a>. They enable individual brain cells to form new connections with surrounding cells, which can change how the brain works even after the drug's effects have worn off <a class="yt-timestamp" data-t="00:09:06">[00:09:06]</a>. This process can essentially "rewire" how the brain processes certain emotions or desires <a class="yt-timestamp" data-t="00:09:15">[00:09:15]</a>. Dr. Matthew Johnson, a professor of Psychiatry and Behavioral Sciences at Johns Hopkins, explains that conditions like addiction, anxiety, and depression are "characterized by a narrowed mental and behavioral repertoire," and "psychedelics seem to have this ability to really powerfully blast people out of those ruts" <a class="yt-timestamp" data-t="00:08:51">[00:08:51]</a>.

## [[history_and_legal_status_of_psychedelics | History and Legal Status of Psychedelics]]

Historically, psychedelics like psilocybin mushrooms and peyote (containing mescaline) have been used in religious rituals by various cultures, including indigenous groups in the Americas <a class="yt-timestamp" data-t="00:04:24">[00:04:24]</a>.

In the 1900s, psychedelics were legal and accessible in the United States, with companies even sending LSD to doctors for experimental use <a class="yt-timestamp" data-t="00:04:34">[00:04:34]</a>. At this time, they were considered an [[therapeutic_potential_and_research_on_psychedelics | exciting area of medical research]] <a class="yt-timestamp" data-t="00:00:45">[00:00:45]</a>.

However, the cultural association of psychedelics with the counter-culture movement of the 1960s, coupled with negative headlines and growing widespread fear, led to a significant shift in [[public_perception_and_the_war_on_drugs | public opinion]] <a class="yt-timestamp" data-t="00:04:52">[00:04:52]</a>.

### The [[public_perception_and_the_war_on_drugs | War on Drugs]] and its Impact

By the 1980s, the United States declared a "[[public_perception_and_the_war_on_drugs | War on Drugs]]," banning psychedelics and altering the course of research, often making it "much darker" <a class="yt-timestamp" data-t="00:00:48">[00:00:48]</a>. The decision to restrict human research was largely a "socio-political phenomenon" rather than being supported by data suggesting the drugs were too dangerous <a class="yt-timestamp" data-t="00:05:31">[00:05:31]</a>.

Research conducted during this period often seemed to support the government's narrative that psychedelics were extremely dangerous <a class="yt-timestamp" data-t="00:05:49">[00:05:49]</a>. A notable example is a 2002 Johns Hopkins study on ecstasy's effects on monkey brains, which concluded that one night of ecstasy use could cause permanent brain damage <a class="yt-timestamp" data-t="00:06:03">[00:06:03]</a>. This study, published in the journal *Science*, also reported a 20% mortality rate among tested animals <a class="yt-timestamp" data-t="00:06:25">[00:06:25]</a>. A year later, the researchers retracted their own study, admitting they had accidentally injected the monkeys with methamphetamines instead of ecstasy <a class="yt-timestamp" data-t="00:06:49">[00:06:49]</a>. Despite the retraction, this misinformation significantly impacted public understanding of psychedelics for decades <a class="yt-timestamp" data-t="00:06:59">[00:06:59]</a>.

## [[therapeutic_potential_and_research_on_psychedelics | Therapeutic Potential and Research on Psychedelics]]

In the last decade, there has been a resurgence in research and interest in psychedelics <a class="yt-timestamp" data-t="00:07:28">[00:07:28]</a>. New research suggests they could offer major health benefits <a class="yt-timestamp" data-t="00:01:24">[00:01:24]</a>.

Researchers are exploring their potential for:
*   **Anxiety and Depression:** One study in the *Journal of Psychopharmacology* found that a high dose of psilocybin relieved anxiety and depression in cancer patients for six months <a class="yt-timestamp" data-t="00:07:46">[00:07:46]</a>. Psilocybin is also being studied for major depressive disorder <a class="yt-timestamp" data-t="00:08:29">[00:08:29]</a>.
*   **PTSD:** A study in *Nature* reported that two-thirds of patients treated with MDMA no longer experienced PTSD <a class="yt-timestamp" data-t="00:07:54">[00:07:54]</a>. MDMA is considered "most confident" in the treatment of PTSD <a class="yt-timestamp" data-t="00:08:19">[00:08:19]</a>.
*   **Addiction:** Psilocybin shows promise in the treatment of alcoholism and for smoking cessation <a class="yt-timestamp" data-t="00:08:24">[00:08:24]</a>.

If these claims prove true, psychedelics could effectively treat disorders affecting millions of people, indicating a "big mistake" in how these drugs were previously classified <a class="yt-timestamp" data-t="00:01:28">[00:01:28]</a>.

### Important Considerations

Despite the promising research, psychedelics are not for everyone <a class="yt-timestamp" data-t="00:09:21">[00:09:21]</a>. For individuals with a family history of schizophrenia, research indicates that psychedelics could trigger manic or psychotic episodes <a class="yt-timestamp" data-t="00:09:26">[00:09:26]</a>. It's crucial not to overhype science that is still in progress <a class="yt-timestamp" data-t="00:09:31">[00:09:31]</a>.

## [[future_of_psychedelic_legalization_and_regulation | Future of Psychedelic Legalization and Regulation]]

The conversation surrounding psychedelics is moving rapidly, with current research showing enough promise for some drugs to be on the path to FDA approval <a class="yt-timestamp" data-t="00:10:19">[00:10:19]</a>. Dr. Matthew Johnson anticipates MDMA could be approved for PTSD in the US by the FDA within a year or two, followed by psilocybin approval a year or two after that <a class="yt-timestamp" data-t="00:10:24">[00:10:24]</a>.

### Models for Legalization

Unlike cannabis, which can be recreationally purchased in some states, the future of psychedelic legalization is unlikely to immediately allow unsupervised personal use <a class="yt-timestamp" data-t="00:10:40">[00:10:40]</a>. The current debate largely focuses on legalizing psychedelics exclusively within supervised settings <a class="yt-timestamp" data-t="00:11:10">[00:11:10]</a>.

Two primary models are being considered:
1.  **FDA-Approved, Doctor-Prescribed, Supervised Setting:** This model envisions doctors prescribing MDMA and psilocybin, with a licensed therapist supervising the "trip" in certified clinics <a class="yt-timestamp" data-t="00:11:15">[00:11:15]</a>. Patients would lie down, often with an eye mask and music, under professional supervision <a class="yt-timestamp" data-t="00:11:26">[00:11:26]</a>.
2.  **State-Level Legalization in Supervised Settings:** States like Oregon and Colorado have legalized psilocybin for use in "healing centers" where a facilitator, rather than a doctor, supervises the experience <a class="yt-timestamp" data-t="00:12:03">[00:12:03]</a>. While these laws are in place, centers are not yet open <a class="yt-timestamp" data-t="00:12:18">[00:12:18]</a>.

The overarching vision for taking psychedelics, whether FDA-approved or state-legalized, currently emphasizes supervised settings <a class="yt-timestamp" data-t="00:12:23">[00:12:23]</a>. The long-term goal is to base regulation on robust scientific research, avoiding unwarranted fear or hype <a class="yt-timestamp" data-t="00:12:42">[00:12:42]</a>. The story of psychedelics serves as a reminder of how controlling something not fully understood can stifle progress and potentially help millions of people struggling with health conditions <a class="yt-timestamp" data-t="00:12:52">[00:12:52]</a>.